BioSpace News Archive

Crystal Pharmatech’s CDMO Business Unit - Crystal Formulations Services Successfully Passed EU QP Audit

Recently, Crystal Formulations Services, the CDMO Business Unit of Crystal Pharmatech has achieved a significant milestone by successfully passing the on-site audit conducted by the European Qualified Person, evaluating its GMP quality system and production facilities.

January 31, 2024
·
2 min read
Biotech Bay

Pulse Biosciences Announces Preliminary Findings from its CellFX nsPFA 360 Cardiac Catheter First-In-Human Feasibility Study to be Featured in Podium Presentation at the AF Symposium

Pulse Biosciences, Inc. (Nasdaq: PLSE) today announced that its nsPFA technology will be featured in a podium presentation at the 29th Annual AF Symposium in Boston, Massachusetts, on February 2, 2024 at 10:00am ET.

January 31, 2024
·
4 min read
Pharm Country

Savara to Present at Two Upcoming Healthcare Conferences

Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will be participating at the following investor healthcare conferences.

January 31, 2024
·
1 min read
BioMidwest

Neuronoff Announces Successful First-in-Human Study of Injectrode Technology for Chronic Pain

Neuronoff, Inc. today announced the successful completion of the first-in-human implant of the Injectrode®.

January 31, 2024
·
3 min read
Stemtech Corporation Expands Global Reach with New License Agreement in Africa

Stemtech Corporation announces a significant milestone in its global expansion strategy with the signing of a license Agreement with an established direct sales company, based in Kenya.

January 31, 2024
·
5 min read
Launching our most comprehensive test and expanding into new global markets

Genetic Technologies Limited, is at the forefront in personalised predictive genomics, reshaping the healthcare landscape with its inventive strategy for early disease detection and personalized wellness is pleased to share Business update for the quarter ending 31 December 2023.

January 31, 2024
·
7 min read
HKG epiTherapeutics Limited Announces the Launch of its MetaGen Mutations Panel

HKG epiTherapeutics Limited announced today the launch of its new product, MetaGen Mutations Panel, an innovative genetic methylation test, which evaluates specific genes that offer individuals unparalleled insights into their genetic profiles and their effects on health and aging.

January 31, 2024
·
2 min read
BioMidwest

Jaguar Gene Therapy Announces FDA Clearance of IND to Study JAG201 in a Genetic Form of Autism Spectrum Disorder and Phelan-McDermid Syndrome

Jaguar Gene Therapy today announced the U.S. Food and Drug Administration (FDA) has cleared the company’s Investigational New Drug (IND) Application for JAG201, a gene therapy for a genetic form of autism spectrum disorder (ASD) and Phelan-McDermid syndrome (PMS).

January 31, 2024
·
7 min read
Pharm Country

KaliVir Announces Opening of GMP Cleanroom Facility, Increasing Manufacturing Capacity for Oncolytic Viruses

KaliVir Immunotherapeutics, Inc. has unveiled its state-of-the-art GMP cleanroom facility to manufacture its pipeline of oncolytic viruses.

January 31, 2024
·
2 min read
IRLAB: Invitation to the Year-end Report 2023 Presentation and Webcast

IRLAB Therapeutics announced that the company will hold a presentation in conjunction with the publication of the Year-end report for the period January-December 2023.

January 31, 2024
·
1 min read